Cargando…

Optimization strategy for the early timing of bronchoalveolar lavage treatment for children with severe mycoplasma pneumoniae pneumonia

BACKGROUND: Early evaluation of severe mycoplasma pneumoniae pneumonia (SMPP) and the prompt utilization of fiberoptic bronchoscopic manipulation can effectively alleviate complications and restrict the progression of sequelae. This study aim to establish a nomogram forecasting model for SMPP in chi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xiangtao, Lu, Weihong, Wang, Tuanjie, Xiao, Aiju, Guo, Xixia, Xu, Yali, Li, Shujun, Liu, Xue, Zeng, Hanshi, He, Shaoru, Zhang, Xingliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557288/
https://www.ncbi.nlm.nih.gov/pubmed/37798699
http://dx.doi.org/10.1186/s12879-023-08619-9
_version_ 1785117057842413568
author Wu, Xiangtao
Lu, Weihong
Wang, Tuanjie
Xiao, Aiju
Guo, Xixia
Xu, Yali
Li, Shujun
Liu, Xue
Zeng, Hanshi
He, Shaoru
Zhang, Xingliang
author_facet Wu, Xiangtao
Lu, Weihong
Wang, Tuanjie
Xiao, Aiju
Guo, Xixia
Xu, Yali
Li, Shujun
Liu, Xue
Zeng, Hanshi
He, Shaoru
Zhang, Xingliang
author_sort Wu, Xiangtao
collection PubMed
description BACKGROUND: Early evaluation of severe mycoplasma pneumoniae pneumonia (SMPP) and the prompt utilization of fiberoptic bronchoscopic manipulation can effectively alleviate complications and restrict the progression of sequelae. This study aim to establish a nomogram forecasting model for SMPP in children and explore an optimal early therapeutic bronchoalveolar lavage (TBAL) treatment strategy. METHODS: This retrospective study included children with mycoplasma pneumoniae pneumonia (MPP) from January 2019 to December 2021. Multivariate logistic regression analysis was used to screen independent risk factors for SMPP and establish a nomogram model. The bootstrap method was employed and a receiver operator characteristic (ROC) curve was drawn to evaluate the accuracy and robustness of the model. Kaplan–Meier analysis was used to assess the effect of lavage and hospitalization times. RESULTS: A total of 244 cases were enrolled in the study, among whom 68 with SMPP and 176 with non-SMPP (NSMPP). A prediction model with five independent risk factors: left upper lobe computed tomography (CT) score, sequential organ failure assessment (SOFA) score, acute physiology and chronic health assessment (APACHE) II score, bronchitis score (BS), and c-reactive protein (CRP) was established based on the multivariate logistic regression analysis. The ROC curve of the prediction model showed the area under ROC curve (AUC) was 0.985 (95% confidence interval (CI) 0.972–0.997). The Hosmer–Lemeshow goodness-of-fit test results showed that the nomogram model predicted the risk of SMPP well (χ2 = 2.127, P = 0.977). The log-rank result suggested that an early BAL treatment could shorten MPP hospitalization time (P = 0.0057). CONCLUSION: This nomogram model, based on the left upper lobe CT score, SOFA score, APACHE II score, BS, and CRP level, represents a valuable tool to predict the risk of SMPP in children and optimize the timing of TBAL.
format Online
Article
Text
id pubmed-10557288
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105572882023-10-07 Optimization strategy for the early timing of bronchoalveolar lavage treatment for children with severe mycoplasma pneumoniae pneumonia Wu, Xiangtao Lu, Weihong Wang, Tuanjie Xiao, Aiju Guo, Xixia Xu, Yali Li, Shujun Liu, Xue Zeng, Hanshi He, Shaoru Zhang, Xingliang BMC Infect Dis Research BACKGROUND: Early evaluation of severe mycoplasma pneumoniae pneumonia (SMPP) and the prompt utilization of fiberoptic bronchoscopic manipulation can effectively alleviate complications and restrict the progression of sequelae. This study aim to establish a nomogram forecasting model for SMPP in children and explore an optimal early therapeutic bronchoalveolar lavage (TBAL) treatment strategy. METHODS: This retrospective study included children with mycoplasma pneumoniae pneumonia (MPP) from January 2019 to December 2021. Multivariate logistic regression analysis was used to screen independent risk factors for SMPP and establish a nomogram model. The bootstrap method was employed and a receiver operator characteristic (ROC) curve was drawn to evaluate the accuracy and robustness of the model. Kaplan–Meier analysis was used to assess the effect of lavage and hospitalization times. RESULTS: A total of 244 cases were enrolled in the study, among whom 68 with SMPP and 176 with non-SMPP (NSMPP). A prediction model with five independent risk factors: left upper lobe computed tomography (CT) score, sequential organ failure assessment (SOFA) score, acute physiology and chronic health assessment (APACHE) II score, bronchitis score (BS), and c-reactive protein (CRP) was established based on the multivariate logistic regression analysis. The ROC curve of the prediction model showed the area under ROC curve (AUC) was 0.985 (95% confidence interval (CI) 0.972–0.997). The Hosmer–Lemeshow goodness-of-fit test results showed that the nomogram model predicted the risk of SMPP well (χ2 = 2.127, P = 0.977). The log-rank result suggested that an early BAL treatment could shorten MPP hospitalization time (P = 0.0057). CONCLUSION: This nomogram model, based on the left upper lobe CT score, SOFA score, APACHE II score, BS, and CRP level, represents a valuable tool to predict the risk of SMPP in children and optimize the timing of TBAL. BioMed Central 2023-10-05 /pmc/articles/PMC10557288/ /pubmed/37798699 http://dx.doi.org/10.1186/s12879-023-08619-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wu, Xiangtao
Lu, Weihong
Wang, Tuanjie
Xiao, Aiju
Guo, Xixia
Xu, Yali
Li, Shujun
Liu, Xue
Zeng, Hanshi
He, Shaoru
Zhang, Xingliang
Optimization strategy for the early timing of bronchoalveolar lavage treatment for children with severe mycoplasma pneumoniae pneumonia
title Optimization strategy for the early timing of bronchoalveolar lavage treatment for children with severe mycoplasma pneumoniae pneumonia
title_full Optimization strategy for the early timing of bronchoalveolar lavage treatment for children with severe mycoplasma pneumoniae pneumonia
title_fullStr Optimization strategy for the early timing of bronchoalveolar lavage treatment for children with severe mycoplasma pneumoniae pneumonia
title_full_unstemmed Optimization strategy for the early timing of bronchoalveolar lavage treatment for children with severe mycoplasma pneumoniae pneumonia
title_short Optimization strategy for the early timing of bronchoalveolar lavage treatment for children with severe mycoplasma pneumoniae pneumonia
title_sort optimization strategy for the early timing of bronchoalveolar lavage treatment for children with severe mycoplasma pneumoniae pneumonia
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557288/
https://www.ncbi.nlm.nih.gov/pubmed/37798699
http://dx.doi.org/10.1186/s12879-023-08619-9
work_keys_str_mv AT wuxiangtao optimizationstrategyfortheearlytimingofbronchoalveolarlavagetreatmentforchildrenwithseveremycoplasmapneumoniaepneumonia
AT luweihong optimizationstrategyfortheearlytimingofbronchoalveolarlavagetreatmentforchildrenwithseveremycoplasmapneumoniaepneumonia
AT wangtuanjie optimizationstrategyfortheearlytimingofbronchoalveolarlavagetreatmentforchildrenwithseveremycoplasmapneumoniaepneumonia
AT xiaoaiju optimizationstrategyfortheearlytimingofbronchoalveolarlavagetreatmentforchildrenwithseveremycoplasmapneumoniaepneumonia
AT guoxixia optimizationstrategyfortheearlytimingofbronchoalveolarlavagetreatmentforchildrenwithseveremycoplasmapneumoniaepneumonia
AT xuyali optimizationstrategyfortheearlytimingofbronchoalveolarlavagetreatmentforchildrenwithseveremycoplasmapneumoniaepneumonia
AT lishujun optimizationstrategyfortheearlytimingofbronchoalveolarlavagetreatmentforchildrenwithseveremycoplasmapneumoniaepneumonia
AT liuxue optimizationstrategyfortheearlytimingofbronchoalveolarlavagetreatmentforchildrenwithseveremycoplasmapneumoniaepneumonia
AT zenghanshi optimizationstrategyfortheearlytimingofbronchoalveolarlavagetreatmentforchildrenwithseveremycoplasmapneumoniaepneumonia
AT heshaoru optimizationstrategyfortheearlytimingofbronchoalveolarlavagetreatmentforchildrenwithseveremycoplasmapneumoniaepneumonia
AT zhangxingliang optimizationstrategyfortheearlytimingofbronchoalveolarlavagetreatmentforchildrenwithseveremycoplasmapneumoniaepneumonia